Large GLP-1 Drug Review Takes Closer Look at Risks, Rewards

(MedPage Today) -- GLP-1 medications showed a range of potential benefits and safety concerns in an umbrella review of non-cardiometabolic outcomes, though the data quality for many remained limited. Across 60 meta-analyses that assessed 116 non...
Source
MedPage Today
Opens original article in a new tab



